Expression and clinical importance of a newly discovered alternative splice variant of the gene for acrosin binding protein found in human brain tumors

[1]Ono T, Kurashige T, Harada N, Noguchi Y, Saika T, Niikawa N, et al. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc Natl Acad Sci U S A. 2001; 98:3282–7.OnoTKurashigeTHaradaNNoguchiYSaikaTNiikawaNIdentification of proacrosin binding protein sp32 precursor as a human cancer/testis antigenProc Natl Acad Sci U S A2001983282710.1073/pnas.041625098Search in Google Scholar

[2]Baba T, Michikawa Y, Kashiwabara S, Arai Y. Proacrosin activation in the presence of a 32-kDa protein from boar spermatozoa. Biochem Biophys Res Commun. 1989; 160:1026–32.BabaTMichikawaYKashiwabaraSAraiYProacrosin activation in the presence of a 32-kDa protein from boar spermatozoaBiochem Biophys Res Commun198916010263210.1016/S0006-291X(89)80105-6Search in Google Scholar

[3]Baba T, Niida Y, Michikawa Y, Kashiwabara S, Kodaira K, Takenaka M, et al. An acrosomal protein, sp32, in mammalian sperm is a binding protein specific for two proacrosins and an acrosin intermediate. J Biol Chem. 1994; 269:10133–40.BabaTNiidaYMichikawaYKashiwabaraSKodairaKTakenakaMAn acrosomal protein, sp32, in mammalian sperm is a binding protein specific for two proacrosins and an acrosin intermediateJ Biol Chem1994269101334010.1016/S0021-9258(17)37000-XSearch in Google Scholar

[4]Wilkinson MF, Kleeman J, Richards J, MacLeod CL. A novel oncofetal gene is expressed in a stage-specific manner in murine embryonic development. Dev Biol. 1990; 141:451–5.WilkinsonMFKleemanJRichardsJMacLeodCLA novel oncofetal gene is expressed in a stage-specific manner in murine embryonic developmentDev Biol1990141451510.1016/0012-1606(90)90400-DSearch in Google Scholar

[5]Ono T, Sato S, Kimura N, Tanaka M, Shibuya A, Old LJ, Nakayama E. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen. Int J Cancer. 2000; 88:845–51.OnoTSatoSKimuraNTanakaMShibuyaAOldLJNakayamaESerological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigenInt J Cancer2000888455110.1002/1097-0215(20001215)88:6<845::AID-IJC1>3.0.CO;2-NSearch in Google Scholar

[6]Li X, Yan J, Fan R, Luo B, Zhang Q, Lin Y, et al. Serum immunore-activity of cancer/testis antigen OY TES-1 and its tissues expression in glioma. Oncol Lett. 2017; 13:3080–6.LiXYanJFanRLuoBZhangQLinYSerum immunore-activity of cancer/testis antigen OY TES-1 and its tissues expression in gliomaOncol Lett2017133080610.3892/ol.2017.5799Search in Google Scholar

[7]Fu X-D, Ares M, Jr. Context-dependent control of alternative splicing by RNA binding proteins. Nat Rev Genet. 2014; 15:689–701.FuX-DAresMJrContext-dependent control of alternative splicing by RNA binding proteinsNat Rev Genet20141568970110.1038/nrg3778Search in Google Scholar

[8]Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature. 2001; 409(6822):860–921.LanderESLintonLMBirrenBNusbaumCZodyMCBaldwinJInitial sequencing and analysis of the human genomeNature2001409682286092110.1038/35057062Search in Google Scholar

[9]Andreadis A. Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases. Biochim Biophys Acta. 2005; 1739:91–103.AndreadisATau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseasesBiochim Biophys Acta200517399110310.1016/j.bbadis.2004.08.010Search in Google Scholar

[10]Dvinge H, Kim E, Abdel-Wahab O, Bradley RK. RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer. 2016; 16:413–30.DvingeHKimEAbdel-WahabOBradleyRKRNA splicing factors as oncoproteins and tumour suppressorsNat Rev Cancer2016164133010.1038/nrc.2016.51Search in Google Scholar

[11]Kanemori Y, Koga Y, Sudo M, Kang W, Kashiwabara S-I, Ikawa M, et al. Biogenesis of sperm acrosome is regulated by pre-mRNA alternative splicing of Acrbp in the mouse. Proc Natl Acad Sci U S A. 2016; 113:E3696–705.KanemoriYKogaYSudoMKangWKashiwabaraS-IIkawaMBiogenesis of sperm acrosome is regulated by pre-mRNA alternative splicing of Acrbp in the mouseProc Natl Acad Sci U S A2016113E369670510.1073/pnas.1522333113Search in Google Scholar

[12]Black MW, Tuan A, Jonasson E. Cloning yeast actin cDNA leads to an investigative approach for the molecular biology laboratory. Biochem Mol Biol Educ. 2008; 36:217–24.BlackMWTuanAJonassonECloning yeast actin cDNA leads to an investigative approach for the molecular biology laboratoryBiochem Mol Biol Educ2008362172410.1002/bmb.20171Search in Google Scholar

[13]Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica. 2016; 131:803–20.LouisDNPerryAReifenbergerGvon DeimlingAFigarella-BrangerDCaveneeWKThe 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica20161318032010.1007/s00401-016-1545-1Search in Google Scholar

[14]Pertea M, Shumate A, Pertea G, Varabyou A, Breitwieser FP, Chang Y-C. CHESS: a new human gene catalog curated from thousands of large-scale RNA sequencing experiments reveals extensive transcriptional noise. Genome Biol. 2018; 19:208. doi: 10.1186/s13059-018-1590-2PerteaMShumateAPerteaGVarabyouABreitwieserFPChangY-CCHESS: a new human gene catalog curated from thousands of large-scale RNA sequencing experiments reveals extensive transcriptional noiseGenome Biol20181920810.1186/s13059-018-1590-2Open DOISearch in Google Scholar

[15]Ast G. How did alternative splicing evolve? Nat Rev Genet. 2004; 5:773–82.AstGHow did alternative splicing evolve?Nat Rev Genet.200457738210.1038/nrg1451Search in Google Scholar

[16]Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, et al. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet. 2012; 8:e1002772. doi: 10.1371/journal.pgen.1002772LovejoyCALiWReisenweberSThongthipSBrunoJde LangeTLoss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathwayPLoS Genet20128e100277210.1371/journal.pgen.1002772Open DOISearch in Google Scholar

[17]Baek D, Green P. Sequence conservation, relative isoform frequencies, and nonsense-mediated decay in evolutionarily conserved alternative splicing. Proc Natl Acad Sci U S A. 2005; 102:12813–8.BaekDGreenPSequence conservation, relative isoform frequencies, and nonsense-mediated decay in evolutionarily conserved alternative splicingProc Natl Acad Sci U S A200510212813810.1073/pnas.0506139102Search in Google Scholar

[18]Grasso C, Modrek B, Xing Y, Lee C. Genome-wide detection of alternative splicing in expressed sequences using partial order multiple sequence alignment graphs. Pac Symp Biocomp. 2004; 9:29–41.GrassoCModrekBXingYLeeCGenome-wide detection of alternative splicing in expressed sequences using partial order multiple sequence alignment graphsPac Symp Biocomp20049294110.1142/9789812704856_0004Search in Google Scholar

[19]Polakoski KL, Parrish RF. Boar proacrosin. Purification and preliminary activation studies of proacrosin isolated from ejaculated boar sperm. J Biol Chem. 1977; 252:1888–94.PolakoskiKLParrishRFBoar proacrosin. Purification and preliminary activation studies of proacrosin isolated from ejaculated boar spermJ Biol Chem197725218889410.1016/S0021-9258(18)71841-3Search in Google Scholar

[20]Parrish RF, Polakoski KL. An apparent high molecular weight form of boar proacrosin resulting from the presence of a protein that binds to proacrosin. Anal Biochem. 1978; 87:108–13.ParrishRFPolakoskiKLAn apparent high molecular weight form of boar proacrosin resulting from the presence of a protein that binds to proacrosinAnal Biochem1978871081310.1016/0003-2697(78)90574-2Search in Google Scholar

[21]Louis DN, Aldape K, Brat DJ, Capper D, Ellison DW, Hawkins C, et al. Announcing cIMPACT-NOW: The Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy. Acta Neuropathologica. 2017; 133:1–3.LouisDNAldapeKBratDJCapperDEllisonDWHawkinsCAnnouncing cIMPACT-NOW: The Consortium to Inform Molecular and Practical Approaches to CNS Tumor TaxonomyActa Neuropathologica20171331310.1007/s00401-016-1646-xSearch in Google Scholar

[22]Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, et al. Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell. 2017; 31:737–54.e6. doi: 10.1016/j.ccell.2017.05.005CavalliFMGRemkeMRampasekLPeacockJShihDJHLuuBIntertumoral heterogeneity within medulloblastoma subgroupsCancer Cell20173173754.e610.1016/j.ccell.2017.05.005Open DOISearch in Google Scholar